MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with M

Methenamine

Methenamine hippurate 1g tablets

Use with caution

Stability notes for Methenamine hippurate 1g tablets

Light sensitive medicine. Store in light resistant container.   Moisture sensitive medicine. Store in airtight (sealed) MCA  Manufacturer recommends storing in original container.
No stability data in MCAs available.

Provenance

This recommendation is based on the products Hiprex 1g tablets (Viatris) and methenamine hippurate 1g tablets (ADVANZ Pharma).

Suppliers (8) of Methenamine hippurate 1g tablets
Hiprex 1g tablets (CST Pharma Ltd)
Hiprex 1g tablets (Pilsco Ltd)
Hiprex 1g tablets (Viatris UK Healthcare Ltd)
Methenamine hippurate 1g tablets (A A H Pharmaceuticals Ltd)
Methenamine hippurate 1g tablets (Advanz Pharma)
Methenamine hippurate 1g tablets (Alliance Healthcare (Distribution) Ltd)
Methenamine hippurate 1g tablets (Brown & Burk UK Ltd)
Methenamine hippurate 1g tablets (Medihealth (Northern) Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.